Aspirin Resistance in Hypertensive Patients

被引:22
作者
Ozben, Beste [1 ]
Tanrikulu, Azra M. [1 ]
Ozben, Tomris [2 ]
Caymaz, Oguz [1 ]
机构
[1] Marmara Univ, Dept Cardiol, Fac Med, Istanbul, Turkey
[2] Akdeniz Univ, Dept Biochem, Fac Med, TR-07058 Antalya, Turkey
关键词
LOW-DOSE ASPIRIN; PLATELET RESPONSE; DIABETES-MELLITUS; IIIA POLYMORPHISM; BLOOD-PRESSURE; RISK-FACTORS; IN-VITRO; PREVALENCE; NONRESPONSIVENESS; PREVENTION;
D O I
10.1111/j.1751-7176.2010.00307.x
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Aspirin resistance is associated with poor clinical prognosis. The authors investigated aspirin resistance in 200 hypertensive patients (111 men, age: 68.3 +/- 11.4 years) by the Ultegra Rapid Platelet Function Assay-ASA (Accumetrics Inc., San Diego, CA). Aspirin resistance was defined as an aspirin reaction unit >= 550. Aspirin resistance was detected in 42 patients. Aspirin resistance was present in 25.6% of the patients with poor blood pressure control, while in 17.8% of the patients with controlled blood pressure (P=.182). Female gender and creatinine levels were significantly higher (P=.028 and P=.030, respectively), while platelet count was significantly lower (P=.007) in aspirin-resistant patients. Multivariate analysis revealed that female gender (odds ratio [OR], 2.445; P=.045), creatinine levels (OR, 1.297; P=.015) and platelet count (OR, 0.993; P=.005) were independent predictors of aspirin resistance. The frequency of aspirin resistance is not low in hypertensive patients. Female hypertensive patients, especially, with higher creatinine levels and lower platelet count are at higher risk for aspirin resistance. J Clin Hypertens (Greenwich). 2010; 12: 714-720. (C) 2010 Wiley Periodicals, Inc.
引用
收藏
页码:714 / 720
页数:7
相关论文
共 43 条
[1]   A new definition of aspirin non-responsiveness by Platelet Function Analyzer-100™ and its predictors [J].
Abaci, A ;
Caliskan, M ;
Bayram, F ;
Yilmaz, Y ;
Cetin, M ;
Unal, A ;
Cetin, S .
PLATELETS, 2006, 17 (01) :7-13
[2]   Defective platelet response to arachidonic acid and thromboxane A2 in subjects with PlA2 polymorphism of β3 subunit (glycoprotein IIIa) [J].
Andrioli, G ;
Minuz, P ;
Solero, P ;
Pincelli, S ;
Ortolani, R ;
Lussignoli, S ;
Bellavite, P .
BRITISH JOURNAL OF HAEMATOLOGY, 2000, 110 (04) :911-918
[3]   Resistance to Aspirin and Thienopyridines in Diabetes Mellitus and Metabolic Syndrome [J].
Anfossi, Giovanni ;
Russo, Isabella ;
Trovati, Mariella .
CURRENT VASCULAR PHARMACOLOGY, 2008, 6 (04) :313-328
[4]  
[Anonymous], 1988, LANCET, V2, P349
[5]  
[Anonymous], COCHRANE DATABASE SY
[6]  
Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71
[7]   Aspirin resistance in secondary stroke prevention [J].
Berrouschot, J ;
Schwetlick, B ;
von Twickel, G ;
Fischer, C ;
Uhlemann, H ;
Siegemund, T ;
Siegemund, A ;
Roessler, A .
ACTA NEUROLOGICA SCANDINAVICA, 2006, 113 (01) :31-35
[8]   Resistance to aspirin in increased by ST-elevation myocardial infarction and correlates with adenosine diphosphate levels [J].
Borna C. ;
Lazarowski E. ;
van Heusden C. ;
Öhlin H. ;
Erlinge D. .
Thrombosis Journal, 3 (1)
[9]   Pharmacodynamic interaction of naproxen with low-dose aspirin in healthy subjects [J].
Capone, ML ;
Sciulli, MG ;
Tacconelli, S ;
Grana, M ;
Ricciotti, E ;
Renda, G ;
Di Gregorio, P ;
Merciaro, G ;
Patrignani, P .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (08) :1295-1301
[10]   Cyclooxygenase inhibitors and the antiplatelet effects of aspirin. [J].
Catella-Lawson, F ;
Reilly, MP ;
Kapoor, SC ;
Cucchiara, AJ ;
DeMarco, S ;
Tournier, B ;
Vyas, SN ;
FitzGerald, GA .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (25) :1809-1817